42Indexed trials
Market Rank #41 · Evidence Tier A
New Zealand
Neuroscience Intelligence
New Zealand neuroscience intelligence: 42 indexed trials, 24 institutions, research score 29.27.
11Recruiting
24Research institutions
29.3Research score
Evidence profile
28Sponsors
16Disease areas
0Institution works
0Institution citations
Evidence signals
Research score 29.3 · Data confidence 100.00 · Evidence 29.3
Data confidence measures presence of evidence layers, not a probability of success. Scores are comparative decision-support signals, not guaranteed market size or commercial outcomes.
Leading disease areas
parkinsons15trials
other_neurology4trials
stroke4trials
huntingtons2trials
multiple_sclerosis2trials
alzheimers2trials
autism2trials
epilepsy2trials
schizophrenia2trials
neurodevelopmental_other1trials
Leading indexed sponsors
Merck Sharp & Dohme LLC10trials
Pfizer3trials
Celgene2trials
Boehringer Ingelheim2trials
Forest Laboratories2trials
Chelsea Therapeutics1trials
BRC Operations Pty. Ltd.1trials
Friedreich's Ataxia Research Alliance1trials
Boston Children's Hospital1trials
Cochlear1trials